Cargando…

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer

BACKGROUND: Cisplatin-based chemotherapy increases the risk of cardiovascular and renal disease. OBJECTIVES: We aimed to define the time course, pathophysiology, and approaches to prevent cardiovascular disease associated with cisplatin-based chemotherapy. METHODS: Two cohorts of patients with a his...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cameron, Alan C., McMahon, Kelly, Hall, Mark, Neves, Karla B., Rios, Francisco J., Montezano, Augusto C., Welsh, Paul, Waterston, Ashita, White, Jeff, Mark, Patrick B., Touyz, Rhian M., Lang, Ninian N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539369/ https://www.ncbi.nlm.nih.gov/pubmed/33043304 http://dx.doi.org/10.1016/j.jaccao.2020.06.004

Ejemplares similares

Reply: Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System
por: Cameron, Alan C., et al.
Publicado: (2021)

Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation
por: Cameron, Alan C., et al.
Publicado: (2020)

Role of PARP and TRPM2 in VEGF Inhibitor‐Induced Vascular Dysfunction
por: Neves, Karla B., et al.
Publicado: (2023)

Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury
por: Neves, Karla B, et al.
Publicado: (2019)

Oxidative Stress: A Unifying Paradigm in Hypertension
por: Touyz, Rhian M., et al.
Publicado: (2020)

Notch3 signalling and vascular remodelling in pulmonary arterial hypertension
por: Morris, Hannah E., et al.
Publicado: (2019)

Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells
por: Alves-Lopes, Rheure, et al.
Publicado: (2023)

Vascular Complications of Cancer Chemotherapy
por: Cameron, Alan C., et al.
Publicado: (2016)

Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways
por: Morris, Hannah E., et al.
Publicado: (2023)

Hypertension and Antiangiogenesis: The Janus Face of VEGF Inhibitors
por: Touyz, Rhian M., et al.
Publicado: (2019)

Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity
por: Lang, Ninian N., et al.
Publicado: (2021)

TRPM7, Magnesium, and Signaling
por: Zou, Zhi-Guo, et al.
Publicado: (2019)

Vascular biology of ageing—Implications in hypertension
por: Harvey, Adam, et al.
Publicado: (2015)

ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease
por: Kuriakose, Jithin, et al.
Publicado: (2021)

NOX5: Molecular biology and pathophysiology
por: Touyz, Rhian M., et al.
Publicado: (2019)

Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
por: Harvey, Adam, et al.
Publicado: (2016)

Vascular Biology of Superoxide-Generating NADPH Oxidase 5—Implications in Hypertension and Cardiovascular Disease
por: Touyz, Rhian M., et al.
Publicado: (2019)

Tissue sodium excess is not hypertonic and reflects extracellular volume expansion
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Testicular cancer: improving outcomes with national quality performance indicators
por: Baxter, Mark A, et al.
Publicado: (2020)

Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review
por: Glen, Claire, et al.
Publicado: (2022)

Cardiotoxic effects of angiogenesis inhibitors
por: Dobbin, Stephen J.H., et al.
Publicado: (2021)

Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk Scores
por: Glen, Claire, et al.
Publicado: (2023)

Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension
por: Alves-Lopes, Rhéure, et al.
Publicado: (2021)

Upregulation of Nrf2 and Decreased Redox Signaling Contribute to Renoprotective Effects of Chemerin Receptor Blockade in Diabetic Mice
por: Neves, Karla Bianca, et al.
Publicado: (2018)

Importance of cholesterol-rich microdomains in the regulation of Nox isoforms and redox signaling in human vascular smooth muscle cells
por: Anagnostopoulou, Aikaterini, et al.
Publicado: (2020)

Sex steroids receptors, hypertension, and vascular ageing
por: Connelly, Paul J., et al.
Publicado: (2021)

ER stress and Rho kinase activation underlie the vasculopathy of CADASIL
por: Neves, Karla B., et al.
Publicado: (2019)

Vascular smooth muscle contraction in hypertension
por: Touyz, Rhian M, et al.
Publicado: (2018)

Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function
por: Zou, Zhi-Guo, et al.
Publicado: (2020)

Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications
por: Lucas-Herald, Angela K., et al.
Publicado: (2017)

Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension
por: Camargo, Livia L, et al.
Publicado: (2021)

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive Targets
por: Alves-Lopes, Rhéure, et al.
Publicado: (2019)

Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis
por: Harvey, Adam P., et al.
Publicado: (2017)

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication
por: Montezano, Augusto C., et al.
Publicado: (2023)

Redox signaling, Nox5 and vascular remodeling in hypertension
por: Montezano, Augusto C., et al.
Publicado: (2015)

Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Mediated Redox Signaling and Vascular Remodeling by 16α-Hydroxyestrone in Human Pulmonary Artery Cells: Implications in Pulmonary Arterial Hypertension
por: Hood, Katie Y., et al.
Publicado: (2016)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Touyz, Rhian M., et al.
Publicado: (2021)

Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
por: Hood, Katie Y., et al.
Publicado: (2017)

OR17-05 Hypospadias Is a Predictor of Adverse Cardiometabolic Risk in Adulthood - a Case-Control Study
por: Lucas-Herald, Angela K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ki9mlrbc5b9o8fk67asd2n7imb